Madrigal’s FDA Approval In MASH Ends Years Of Industry Frustration
Executive Summary
As the first approved MASH (formerly NASH) therapy, nearly four years after initially anticipated, Madrigal gets the opportunity to establish a MASH marketplace with Rezdiffra (resmetirom).